STME — StimCell Enegetics Cashflow Statement
0.000.00%
- $9.22m
- $9.88m
Annual cashflow statement for StimCell Enegetics, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.911 | -0.697 | -0.495 | -0.142 | -0.566 |
| Depreciation | |||||
| Non-Cash Items | 0.128 | 0.108 | 0.119 | -0.119 | 0.167 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.22 | 0.138 | 0.104 | 0.116 | 0.257 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.56 | -0.451 | -0.272 | -0.146 | -0.142 |
| Capital Expenditures | -0.002 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.002 | 0 | — | — | — |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.535 | 0.454 | 0.346 | 0.091 | 0.113 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.024 | 0.004 | 0.074 | -0.055 | -0.029 |